<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04582279</url>
  </required_header>
  <id_info>
    <org_study_id>20-002489</org_study_id>
    <nct_id>NCT04582279</nct_id>
  </id_info>
  <brief_title>Lung Ultrasound Artefact Analysis for Exclusion of Acute Rejection in Lung Transplant Recipients</brief_title>
  <official_title>Application of Lung Ultrasound Artefact Analysis for Exclusion of Acute Rejection in Asymptomatic Lung Transplant Recipients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is being done to study a safe and non-invasive way to diagnose lung rejection and&#xD;
      infection.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Lung transplant recipients are at high risk for lung rejection and lung infection after&#xD;
      transplant. This is diagnosed by performing lung bronchoscopies and lung biopsies. These&#xD;
      procedures carry an increased risk for complications and are costly. This study is being done&#xD;
      to study a safe and non-invasive way to diagnose lung rejection and infection.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 28, 2020</start_date>
  <completion_date type="Anticipated">November 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>There is only 1 group of participants being monitored. Every patient will follow the same study procedures</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>This study is not blinded</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Establish predictive value of lung ultrasound</measure>
    <time_frame>Month 0 to month 12</time_frame>
    <description>Determine if lung ultrasound provides the same diagnostic results as bronchoscopy and biopsy</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Post-Lung Transplantation Bronchiectasis</condition>
  <arm_group>
    <arm_group_label>Receiving Ultrasound</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Every patient will receive a lung ultrasound prior to each scheduled bronchoscopy until the study stops.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Lung ultrasound</intervention_name>
    <description>The lung ultrasound will be performed by a trained pulmonologist by gently pressing a probe to various areas of your chest. This is a non-invasive procedure and you should not feel any pain. The ultrasound will take less than 10 minutes.</description>
    <arm_group_label>Receiving Ultrasound</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients (&gt; 18 yrs) who had undergone single/double/heart-lung transplant&#xD;
&#xD;
          -  Asymptomatic&#xD;
&#xD;
          -  Normal spirometry defined as a FEV1 without significant drop from baseline&#xD;
             (significant drop = &gt;10% decrease from baseline)&#xD;
&#xD;
          -  Clear chest radiograph over allograft&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who are unable to consent for the procedure&#xD;
&#xD;
          -  Patients with subcutaneous emphysema or other technical challenges that could&#xD;
             interfere with satisfactory image acquisition- as deemed by the operator.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tathagat Narula, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katelyn Register</last_name>
      <phone>904-953-8503</phone>
      <email>register.katelyn@mayo.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>October 7, 2020</study_first_submitted>
  <study_first_submitted_qc>October 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2020</study_first_posted>
  <last_update_submitted>May 27, 2021</last_update_submitted>
  <last_update_submitted_qc>May 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Tathagat Narula</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Post lung transplant</keyword>
  <keyword>Lung bronchoscopy</keyword>
  <keyword>Lung biopsy</keyword>
  <keyword>Lung rejection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchiectasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

